Fuente de la imagen: http://www.fiercebiotech.com/slideshows/top-10-blockbuster-biotech-drugs?img=10
Enbrel (Etanercept)
Companies: Amgen, Wyeth, Takeda
Sales: $7.66 billion in 2008
Indications: Rheumatoid Arthritis, Juvenile Idiopathic Arthritisc, Ankylosing Spondylitis, Plaque Psoriasis
Fuente: http://www.fiercebiotech.com/slideshows/top-10-blockbuster-biotech-drugs?img=0#ixzz0j67yyzPk
Remicade
Companies: J&J, Schering Plough, Mitsubishi Tanabe
Sales: $6.2 billion in 2008
Indications: Plaque Psoriasi, Rheumatoid Arthritis, Psoriatic Arthritis, Adult Crohn's Disease, Pediatric Crohn's Disease, Ulcerative Colitis, Ankylosing Spondylit:
http://www.fiercebiotech.com/slideshows/top-10-blockbuster-biotech-drugs?img=1#ixzz0j68Q2hY4
Rituxan
Company: Roche
Sales: $5.5B in 2008
Indications: Non-Hodgkin's Lymphoma and Rheumatoid arthritis
http://www.fiercebiotech.com/slideshows/top-10-blockbuster-biotech-drugs?img=2#ixzz0j69PT7Lp
Avastin
Company: Roche
Sales: $3.8 billion in 2008
Indications: Metastatic colorectal cancer, Non-squamous non-small cell lung cancer, Metastatic breast cancer, Glioblastoma, Metastatic renal cell carcinoma.
http://www.fiercebiotech.com/slideshows/top-10-blockbuster-biotech-drugs?img=3#ixzz0j69dWqlC
Herceptin (Trastuzumab)
Company: Roche
Sales: $4.7B in 2008
Indications: Breast Cancer
http://www.fiercebiotech.com/slideshows/top-10-blockbuster-biotech-drugs?img=4#ixzz0j6AoLmck
Humira (Adalimumab)
Company: Abbott
Sales: $4.5 billion in 2008
Indications: Rheumatoid Arthritis, ployarticular juvenile idiopathic arthritis, psoriatic arthritis, Chronic plaque psoriasis, Ankylosing Spondylitis, Chrone's disease
http://www.fiercebiotech.com/slideshows/top-10-blockbuster-biotech-drugs?img=5#ixzz0j6B7wRKG
Lovenox (Enoxaparin)
Company: Sanofi Aventis
Sales: $4 billion in 2008
Indications: DVT Blood Clots
http://www.fiercebiotech.com/slideshows/top-10-blockbuster-biotech-drugs?img=6#ixzz0j6BLNG3B
Lantus (Insulin)
Company: Sanofi Aventis
Sales: $3.6 billion in 2008
Indications: DiabetesRead more:
http://www.fiercebiotech.com/slideshows/top-10-blockbuster-biotech-drugs?img=7#ixzz0j6BVNsee
Aranesp (Darbepoetin)
Company: Amgen
Sales: $3.1 in 2008
Indications: Anemia
http://www.fiercebiotech.com/slideshows/top-10-blockbuster-biotech-drugs?img=8#ixzz0j6BbyuAH
Gardasil
Company: Merck
Sales: $2.8 billion in 2008
Indications: HPV and Cervical cancer preventiona:
http://www.fiercebiotech.com/slideshows/top-10-blockbuster-biotech-drugs?img=9#ixzz0j6Bn2ZwV
